MGMA Meeting Pushes High Tech Patient ID Cards


By Neil Versel, contributing editor

October 21, 2008 | SAN DIEGO—The Medical Group Management Association (MGMA) will push the health insurance industry to standardize patient identification cards with magnetic stripes, bar codes, or embedded chips and has commissioned a study to quantify the potential savings for payers and providers alike.

MGMA wants to go after the perceived low-hanging fruit of administrative waste, specifically in standardizing physician credentialing and patient eligibility and benefits verification. The organization will study the cost to medical practices of making copies of patient insurance cards, manual entry of data—and related transcription errors—telephone calls to check benefits, and delayed collection of co-payments from not having accurate information at the time of service.

“It’s amazing how much waste there is in the system,” MGMA president and chief executive William F. Jessee, M.D., said here Monday at the organization’s annual meeting. Jessee expressed optimism that an IT-enabled, standardized insurance ID card—not a politically radioactive plan like a national patient ID number—will help trim much of the fat that has weighed on health care nationwide.

“We’re soliciting partners to join our call for guidelines for industry-wide adoption of these technologies,” Jessee said. He confirmed that MGMA will be talking to major health insurers, and suggested that standardization follow a health-IT implementation guide developed by the Workgroup for Electronic Data Interchange.

To this end, the Healthcare Administrative Simplification Coalition, which MGMA helped establish in 2005, is meeting next month to design a set of principles for combating waste and inefficiency, Jessee said. The group includes medical societies, health-IT and administrative professional organizations, Microsoft Corp. and several payers, including HumanaUnitedHealthcare the Centers for Medicare and Medicaid Services (CMS).

“Compared to the rest of administrative challenges,” this one is downright simple,” Jessee said, adding, “We picked this one in part because it’s so simple, even a legislator can understand it.”

Earlier this year, lawmakers in the MGMA’s home state of Colorado approved a health reform plan that includes the standardization of printed insurance ID cards, but stops short of mandating machine-readable cards.

Jessee said practices could obtain card readers for $50 or less, though there may be additional costs for interfacing the readers with practice management software. However, the integration may be worth the money for the hassles it could help avert.

In one Monday conference session about online patient-physician communication, Richard Bevington, manager of OB/GYN Specialists of Northern Kentucky (Edgewood, Ky.) explained how a credit-card processing company insisted that the practice register a second merchant account, with all the attendant fees, to add an e-commerce module to the practice’s Web site. This little bit of duplication has caused all sorts of problems for the practice in reconciling online payments with bank statements, Bevington told Digital HealthCare & Productivity.

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Life Science Webcasts & Podcasts

medidata podcast #8 Meeting Today’s Challenges in Clinical Trial Supply Management
Sponsored by: Medidata Solutions Worldwide  

Setting up and managing the clinical trial involves many complex procedures. Among the most challenging are planning and executing the logistics of the trial’s clinical supplies. This podcast focuses in depth on the following topics which trace current practices and future evolution of this crucial aspect of clinical trials:

  • Current practices in clinical trial logistics
  • Comparing advances in clinical supply practices to  other aspects of clinical trials 
  • Where current practices fall short of meeting the challenges
  • Trends and evolving improvements that may change the way logistics are conducted

Listen Now  


More Podcasts

Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .